Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008689 |
---|---|
Receipt number | R000008809 |
Scientific Title | A clinical study on safety and efficacy of sorafenib as maintenance chemotherapy after percutaneous isolated hepatic perfusion chemotherapy (PIHP) for advanced hepatocellular carcinoma |
Date of disclosure of the study information | 2012/09/19 |
Last modified on | 2018/02/17 21:21:32 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/15 00:19:51 | ||
2 | Update | 2012/08/15 00:23:47 | Public title |
|
3 | Update | 2012/08/15 00:27:34 | Public title Public title |
|
4 | Update | 2013/10/16 09:00:13 | Recruitment status |
|
5 | Update | 2015/01/23 16:08:26 | Email Address Address TEL Research ethics review Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
6 | Update | 2016/08/18 12:34:03 | Name of primary person or sponsor Organization |
|
7 | Update | 2018/02/17 21:21:32 | Recruitment status Last follow-up date Date trial data considered complete Date analysis concluded |